» Articles » PMID: 31004677

Strength of Association Between Pentosan Polysulfate and a Novel Maculopathy

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 2019 Apr 21
PMID 31004677
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Incidence and Risk of Retinopathy in Patients With and Without Interstitial Cystitis and Pentosan Polysulfate Sodium Use.

Desjarlais E, Medic V, Kim J J Vitreoretin Dis. 2023; 7(5):412-419.

PMID: 37706083 PMC: 10496808. DOI: 10.1177/24741264231190978.


Hemorrhagic Cystitis: Making Rapid and Shrewd Clinical and Surgical Decisions for Improving Patient Outcomes.

Jefferson F, Linder B Res Rep Urol. 2023; 15:291-303.

PMID: 37404838 PMC: 10317550. DOI: 10.2147/RRU.S320684.


Characteristics of Pentosan Polysulfate Sodium-Associated Maculopathy and Similarities With Other Maculopathies Commonly Managed in a Retina Practice.

Ohning C, Skopis G, Levinson J, Kasi S J Vitreoretin Dis. 2023; 6(2):104-110.

PMID: 37008666 PMC: 9976010. DOI: 10.1177/24741264211020259.


Cystoid Macular Edema Arising 10 Years After Cessation of Pentosan Polysulfate Sodium Successfully Treated With Bevacizumab.

Szelog J, Shah N, Camejo M J Vitreoretin Dis. 2023; 7(1):83-86.

PMID: 37008392 PMC: 9954163. DOI: 10.1177/24741264221136907.


Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Mukhopadhyay C, Boyce T, Gehrs K, Folk J, Mullins R, Luo Y Asia Pac J Ophthalmol (Phila). 2022; 11(2):100-110.

PMID: 35533330 PMC: 9096915. DOI: 10.1097/APO.0000000000000504.